Yeah Nah! that is not a good comparison.
IMO, if the 12 month follow up figure is not well above 50% then I am not sure it will be a viable revenue stream for AVH and I would say that the market will discount the sp. Its interesting that they have not released the 12 month follow up results.
SP if both FDA approvals go through, page-233
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
-0.070(2.78%) |
Mkt cap ! $162.4M | |||
| Open | High | Low | Value | Volume |
| $2.51 | $2.51 | $2.45 | $415.9K | 167.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 14867 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.48 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |